Ceribell, Inc. (CBLL)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$24.72+0.61%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · CBLL
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenues | 102.0 | 89.1 | 65.4 | 45.2 | — |
| Cost of Revenues | 11.3 | 10.8 | 8.7 | 7.1 | — |
| Gross Profit | 90.6 | 78.3 | 56.8 | 38.2 | — |
| Operating Expenses & Income | |||||
| R&D Expenses | 23.0 | 19.1 | 13.6 | 9.0 | — |
| Operating Income | (70.0) | (58.4) | (39.7) | (30.0) | — |
| Earnings from Continuing Operations | |||||
| Interest Expense | — | 1.9 | 2.0 | — | — |
| EBT, Incl. Unusual Items | (66.0) | (53.4) | (40.5) | (29.5) | — |
| Income Tax Expense | — | — | — | 0.0 | — |
| Net Income | |||||
| Net Income | (66.0) | (53.4) | (40.5) | (29.5) | — |
| Per Share | |||||
| Basic EPS | (1.74) | (1.46) | (3.39) | (5.56) | — |
| Diluted EPS | (1.74) | (1.46) | (3.39) | (5.56) | — |
| Revenue per Share | 2.68 | — | — | — | — |
| Basic Weighted Avg Shares | 38.0 | 36.5 | 11.9 | 5.3 | — |
| Diluted Weighted Avg Shares | 38.0 | 36.5 | 11.9 | 5.3 | — |
| Supplemental | |||||
| EBITDA | — | (57.4) | (39.0) | (29.5) | — |
| EBIT | (70.0) | (58.4) | (39.7) | (30.0) | — |
| Effective Tax Rate | — | — | — | -0.0% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.